Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
| Weiss Ratings | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -72.50 | |||
| Price History | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -99.00% | |||
| 3-Year Total Return | -99.50% | |||
| 5-Year Total Return | -99.50% | |||
| 52-Week High % Change | -99.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 27, 2024 | |||
| 52-Week High Price (Date) | May 28, 2024 | |||
| Valuation | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 536.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 500 4157 | |||
| Address | 8275 S. Easter Avenue Las Vegas, NV 89123 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | 1983 | |||
| Profitability | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -66.45% | |||
| Profit Margin | -62.06% | |||
| Management Effectiveness | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -174.44% | |||
| Return on Equity | -- | |||
| Income Statement | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 302.60K | |||
| Total Revenue (TTM) | 302.60K | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 286.40K | |||
| EBITDA (TTM) | -192.70K | |||
| EBIT (TTM) | -201.10K | |||
| Net Income (TTM) | -187.80K | |||
| Net Income Avl. to Common (TTM) | -187.80K | |||
| Total Revenue Growth (Q YOY) | -0.31% | |||
| Earnings Growth (Q YOY) | 74.10% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 75.00% | |||
| Balance Sheet | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 54.50K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -864.60K | |||
| Current Ratio (Q) | 0.058 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 935.30K | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | -864.60K | |||
| Cash Flow | MRPI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.30K | |||
| Cash from Financing (TTM) | 72.50K | |||
| Net Change in Cash (TTM) | -1.70K | |||
| Levered Free Cash Flow (TTM) | -209.00K | |||
| Cash from Operations (TTM) | -71.90K | |||
